⚡ RSI Stock Overbought & Oversold Stocks — 2026-06-01
Automated Relative Strength Index (RSI) momentum scanner identifying Oversold Stocks (RSI < 30), which may indicate potential bullish reversal opportunities, and Overbought Stocks (RSI > 70), which may indicate potential pullback or profit-booking zones. Stocks with RSI between 30 and 70 are considered to be in a neutral momentum range.
| Date | Stock Target | RSI State | RSI Val | Close Price | Next Day Open | Next Day High | Next Day Low | Session Change | Historical Win Edge |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | HFCL | Overbought (Bearish) | 82.91 | ₹182.28 | ₹180.00 | ₹191.39 | ₹176.50 | +3.50 | 44.29% |
| 2026-06-01 | ADANIENT | Overbought (Bearish) | 73.14 | ₹2909.40 | ₹2885.00 | ₹2975.00 | ₹2865.20 | +19.80 | 36.29% |
| 2026-06-01 | CEMPRO | Overbought (Bearish) | 75.90 | ₹1073.80 | ₹1064.10 | ₹1064.10 | ₹1026.30 | +37.80 | 66.67% |
| 2026-06-01 | IDEA | Overbought (Bearish) | 78.59 | ₹13.95 | ₹14.00 | ₹14.20 | ₹13.81 | +0.19 | 39.68% |
| 2026-06-01 | NETWEB | Overbought (Bearish) | 71.20 | ₹4620.10 | ₹4608.90 | ₹4824.50 | ₹4552.30 | +56.60 | 40.54% |
| 2026-06-01 | ITC | Oversold (Bullish) | 24.73 | ₹279.65 | ₹279.50 | ₹283.60 | ₹277.10 | +4.10 | 39.22% |
| 2026-06-01 | LAURUSLABS | Overbought (Bearish) | 76.99 | ₹1388.40 | ₹1388.00 | ₹1390.70 | ₹1370.50 | +17.50 | 44.09% |
| 2026-06-01 | INOXWIND | Oversold (Bullish) | 29.45 | ₹83.84 | ₹83.01 | ₹85.04 | ₹81.62 | +2.03 | 44.74% |
| 2026-06-01 | SAMMAANCAP | Overbought (Bearish) | 75.53 | ₹177.35 | ₹176.62 | ₹181.84 | ₹176.17 | +0.45 | 53.12% |
| 2026-06-01 | POLYCAB | Overbought (Bearish) | 70.29 | ₹9480.50 | ₹9420.00 | ₹9555.50 | ₹9320.50 | +99.50 | 36.81% |
| 2026-06-01 | BRITANNIA | Oversold (Bullish) | 28.50 | ₹5157.50 | ₹5120.50 | ₹5148.00 | ₹5075.00 | +27.50 | 60.53% |
| 2026-06-01 | BDL | Oversold (Bullish) | 29.92 | ₹1204.00 | ₹1192.00 | ₹1213.80 | ₹1182.50 | +21.80 | 53.12% |
| 2026-06-01 | RVNL | Oversold (Bullish) | 23.24 | ₹241.56 | ₹240.00 | ₹241.75 | ₹232.73 | +1.75 | 64.52% |
| 2026-06-01 | NATCOPHARM | Oversold (Bullish) | 25.77 | ₹933.30 | ₹930.00 | ₹954.00 | ₹925.00 | +24.00 | 69.23% |
| 2026-06-01 | THERMAX | Overbought (Bearish) | 73.46 | ₹4992.80 | ₹4950.00 | ₹5005.00 | ₹4800.10 | +149.90 | 55.56% |
| 2026-06-01 | LICI | Oversold (Bullish) | 15.32 | ₹404.85 | ₹401.00 | ₹403.25 | ₹397.10 | +2.25 | 73.53% |
| 2026-06-01 | TATATECH | Overbought (Bearish) | 72.74 | ₹714.80 | ₹711.05 | ₹742.05 | ₹708.05 | +3.00 | 40.0% |
| 2026-06-01 | ZYDUSLIFE | Overbought (Bearish) | 74.40 | ₹1091.20 | ₹1082.00 | ₹1091.10 | ₹1061.10 | +20.90 | 40.94% |
| 2026-06-01 | UBL | Oversold (Bullish) | 24.43 | ₹1286.00 | ₹1286.00 | ₹1324.70 | ₹1276.00 | +38.70 | 40.0% |
| 2026-06-01 | GLAXO | Oversold (Bullish) | 28.76 | ₹2204.40 | ₹2204.30 | ₹2204.30 | ₹2154.00 | 0.00 | 73.47% |
| 2026-06-01 | BLUEDART | Oversold (Bullish) | 29.54 | ₹4720.50 | ₹4720.00 | ₹4768.00 | ₹4700.00 | +48.00 | 53.01% |
| 2026-06-01 | AIAENG | Overbought (Bearish) | 77.26 | ₹4522.70 | ₹4504.80 | ₹4562.90 | ₹4428.70 | +76.10 | 57.75% |
| 2026-06-01 | MINDACORP | Overbought (Bearish) | 73.36 | ₹618.80 | ₹618.00 | ₹634.15 | ₹614.00 | +4.00 | 52.54% |
| 2026-06-01 | SAREGAMA | Overbought (Bearish) | 76.33 | ₹459.75 | ₹457.00 | ₹463.45 | ₹444.25 | +12.75 | 44.29% |
| 2026-06-01 | EIHOTEL | Oversold (Bullish) | 27.84 | ₹288.75 | ₹285.00 | ₹290.70 | ₹283.70 | +5.70 | 58.33% |
⚠️ Educational Disclaimer:
The information, charts, technical indicators, AI-generated insights, and historical performance data on this page are provided solely for educational and informational purposes. This content does not constitute investment advice, financial advice, trading advice, or a recommendation to buy, sell, or hold any security. Market investments are subject to risks, and past performance or AI-generated forecasts do not guarantee future results. Users should perform their own research and consult a qualified financial advisor before making investment decisions. PulseTrackAI is an educational analytics platform and is not registered with SEBI as an Investment Adviser or Research Analyst.